Eli Lilly
NYSE:LLY
$ 1.132,53
+ $7,26 (0,65%)
1.132,53 $
+$7,26 (0,65%)
Real-time: 06/05/2026 15:59

News

5 Stocks Investors Couldn't Stop Buzzing About This Week: AAPL, GOOG, HOOD And More

Retail investors talked up five hot stocks this week (April 27 to May 1) on X and Reddit's r/WallStreetBets: AAPL, GOOG, HOOD, META, LLY.

05/02/2026

S&P 500's Best‑Kept Secret: Why Healthcare Could Be 2026's Breakout Winner

AI‑powered drug discovery, strong earnings upgrades, and rising institutional flows show why healthcare may shift from 2026 laggard to breakout S&P 500 growth story.

05/01/2026

Deal Dispatch: Sirius XM Mulls Purchase Of iHeartMedia, Uber Buys FlyTaxi, Wren Kitchens Bankruptcy

Major M&A deals this week include: Eli Lilly buys Profluent for $2.2 billion, Lazard buys Campbell Lutyens, FreshRealm bankruptcy.

05/01/2026

10 Health Care Stocks With Whale Alerts In Today's Session

05/01/2026

Cantor Fitzgerald Maintains Overweight on Eli Lilly, Raises Price Target to $1230

Cantor Fitzgerald analyst Carter Gould maintains Eli Lilly (NYSE:LLY) with a Overweight and raises the price target from $1205 to $1230.

05/01/2026

Eli Lilly Jumps As Earnings Beat Meets FDA Tightening Drug Compounding Rules

Eli Lilly lifts 2026 outlook after Q1 beat; FDA targets compounded GLP-1 drugs, tightening rules on semaglutide, tirzepatide, liraglutide.

05/01/2026

Stock Market Today: Dow, S&P 500, Nasdaq Futures RiseAs Trump Administration Evades War Powers Deadline— Apple, Twilio, Roblox In Focus (UPDATED)

(Editor’s note: The future prices of benchmark tracking ETFs, the lede, and the headline were updated in the story.) U.S. stock futures shed earlier losses to advance on Friday morning, following Thursday's record advances following mega-cap earnings.

05/01/2026

Eli Lilly Capitalizes On Consumers' 'Love Affair' With Weight Loss Drugs: Gary Black Says Valuation 'Still Looks Compelling'

Gary Black calls Eli Lilly's valuation 'compelling' as Q1 earnings soar, driven by the consumer 'love affair' with GLP-1 weight loss drugs.

05/01/2026

Here's How Much $1000 Invested In Eli Lilly 15 Years Ago Would Be Worth Today

04/30/2026

Hyperscaler Capex Growth Reignites Semi Mania; Jobless Claims This Low Last Seen In 1969

Leading Indicators

04/30/2026
×
Logo
Offer & Services
Features
Pricing
Masters
Trend
Radar
Service & Collaboration
Contact
Help
Affiliate Program
Stock Market Glossary
Company & Legal
Impressum
Privacy Policy
Terms and Conditions

© Copyright 2026 | GROWTH Investing | All Rights Reserved

Important note:

Please note that we do not offer financial services such as investment advice, asset management, or financial brokerage. Our website is solely for providing information and educational content on modern financial strategies and stock analysis. All information presented on this website is for educational purposes and should not be construed as specific investment recommendations. We do not manage client funds and assume no responsibility for individual investment decisions. Each participant is responsible for their own financial decisions and should consult an independent financial advisor if necessary.

The successes, participation figures, and information presented here, provided by Growth Services LLC, are based on our own experiences and those of our clients in the field of stock and chart analysis. They should not be interpreted as an absolute guarantee or a firm promise. Individual success results can vary significantly and depend on numerous factors. The successes presented in our case studies and testimonials reflect the actual results of ourselves and our most dedicated participants and are intended as inspiration, not as a binding commitment. Our offering aims to equip you with the necessary knowledge and skills to perform optimally in the stock market. While we are committed to the success of each individual, we cannot guarantee specific results. Proactive participation and dedication from our clients are essential for success.

This site is not a part of the Facebook, Instagram website or Meta Platforms Inc. Additionally, This site is NOT endorsed by Meta Platforms in any way. FACEBOOK is a trademark of Meta Platforms, Inc.

This website is not affiliated with, endorsed by, or operated by Google LLC. Google is a registered trademark of Google LLC. Our service and offerings are not directly connected to the products or services of Google.